| Balance Sheet of Zydus Lifesciences (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| |
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| EQUITIES AND LIABILITIES |
|
|
|
|
|
|
| SHAREHOLDER'S FUNDS |
|
|
|
|
|
|
| Equity Share Capital |
100.60 |
100.60 |
101.20 |
102.40 |
102.40 |
|
| Total Share Capital |
100.60 |
100.60 |
101.20 |
102.40 |
102.40 |
|
| Reserves and Surplus |
23,852.50 |
19,728.90 |
17,414.60 |
16,897.20 |
12,889.90 |
|
| Total Reserves and Surplus |
23,852.50 |
19,728.90 |
17,414.60 |
16,897.20 |
12,889.90 |
|
| Total Shareholders Funds |
23,953.10 |
19,829.50 |
17,515.80 |
16,999.60 |
12,992.30 |
|
| Minority Interest |
2,405.30 |
2,272.10 |
2,172.50 |
2,054.20 |
1,937.30 |
|
| NON-CURRENT LIABILITIES |
|
|
|
|
|
|
| Long Term Borrowings |
0.00 |
0.00 |
0.00 |
362.10 |
609.50 |
|
| Deferred Tax Liabilities [Net] |
512.60 |
446.50 |
194.40 |
153.80 |
119.70 |
|
| Other Long Term Liabilities |
905.20 |
1,081.10 |
71.20 |
61.30 |
55.10 |
|
| Long Term Provisions |
383.90 |
309.70 |
271.80 |
325.00 |
309.50 |
|
| Total Non-Current Liabilities |
1,801.70 |
1,837.30 |
537.40 |
902.20 |
1,093.80 |
|
| CURRENT LIABILITIES |
|
|
|
|
|
|
| Short Term Borrowings |
3,169.50 |
768.60 |
1,163.20 |
3,833.90 |
3,974.00 |
|
| Trade Payables |
2,305.80 |
2,126.70 |
2,125.00 |
2,137.80 |
2,205.90 |
|
| Other Current Liabilities |
3,114.90 |
2,051.80 |
1,877.10 |
1,502.10 |
1,351.50 |
|
| Short Term Provisions |
451.40 |
394.80 |
365.40 |
365.60 |
329.90 |
|
| Total Current Liabilities |
9,041.60 |
5,341.90 |
5,530.70 |
7,839.40 |
7,861.30 |
|
| Total Capital And Liabilities |
37,201.70 |
29,280.80 |
25,756.40 |
27,795.40 |
23,884.70 |
|
| ASSETS |
|
|
|
|
|
|
| NON-CURRENT ASSETS |
|
|
|
|
|
|
| Tangible Assets |
6,042.00 |
5,803.30 |
5,696.50 |
5,761.60 |
5,550.00 |
|
| Intangible Assets |
1,849.60 |
1,299.20 |
1,020.00 |
1,127.20 |
1,236.30 |
|
| Capital Work-In-Progress |
1,317.90 |
1,111.50 |
1,130.20 |
661.00 |
783.20 |
|
| Fixed Assets |
10,583.50 |
9,525.80 |
7,917.20 |
7,549.80 |
7,569.50 |
|
| Non-Current Investments |
1,556.70 |
968.00 |
927.30 |
934.80 |
631.20 |
|
| Deferred Tax Assets [Net] |
2,343.80 |
1,644.20 |
1,262.40 |
1,095.80 |
1,074.40 |
|
| Long Term Loans And Advances |
0.00 |
0.00 |
2.00 |
0.00 |
0.00 |
|
| Other Non-Current Assets |
429.50 |
375.40 |
826.70 |
589.00 |
547.10 |
|
| Total Non-Current Assets |
20,155.60 |
17,779.40 |
15,740.00 |
15,534.00 |
15,168.70 |
|
| CURRENT ASSETS |
|
|
|
|
|
|
| Current Investments |
4,851.10 |
252.50 |
619.30 |
2,353.20 |
198.90 |
|
| Inventories |
3,944.00 |
3,441.90 |
3,413.30 |
3,719.40 |
3,236.20 |
|
| Trade Receivables |
4,024.70 |
5,220.20 |
4,416.80 |
3,340.30 |
3,127.30 |
|
| Cash And Cash Equivalents |
2,956.80 |
1,105.10 |
573.10 |
1,106.90 |
888.30 |
|
| Short Term Loans And Advances |
77.10 |
1.50 |
0.40 |
0.00 |
0.00 |
|
| OtherCurrentAssets |
1,192.40 |
1,480.20 |
993.50 |
1,741.60 |
1,265.30 |
|
| Total Current Assets |
17,046.10 |
11,501.40 |
10,016.40 |
12,261.40 |
8,716.00 |
|
| Total Assets |
37,201.70 |
29,280.80 |
25,756.40 |
27,795.40 |
23,884.70 |
|
| OTHER ADDITIONAL INFORMATION |
|
|
|
|
|
|
| CONTINGENT LIABILITIES, COMMITMENTS |
|
|
|
|
|
|
| Contingent Liabilities |
1,428.00 |
1,277.10 |
1,315.20 |
1,210.70 |
1,295.50 |
|
| BONUS DETAILS |
|
|
|
|
|
|
| Bonus Equity Share Capital |
72.97 |
72.97 |
72.97 |
72.97 |
72.97 |
|
| NON-CURRENT INVESTMENTS |
|
|
|
|
|
|
| Non-Current Investments Quoted Market Value |
0.00 |
409.30 |
464.20 |
517.50 |
232.40 |
|
| Non-Current Investments Unquoted Book Value |
0.00 |
142.50 |
46.50 |
43.00 |
41.80 |
|
| CURRENT INVESTMENTS |
|
|
|
|
|
|
| Current Investments Quoted Market Value |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Current Investments Unquoted Book Value |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
Source : Dion Global Solutions Limited
